Substance / Medication

Cerivastatin

SNOMED 373443008 UMLS C0528023

Overview

Active Ingredient

cerivastatin

RxNorm CUI

596723

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Hyperlipoproteinemia

Hypercholesterolemia

Hypertriglyceridaemia

Disorder of coronary artery

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

Total Trials

Recruiting

With Results

Recent Trials

Adductor Canal Block After Total Knee Replacement - a Suture-method Catheter vs a Standard Catheter vs a Single Bolus

NCT03142789Phase 4Completed153 enrolled

View all 1 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

Cerivastatin for lowering lipids.

Adams Stephen P, Tiellet Nicholas, Alaeiilkhchi Nima et al. · Cochrane Database Syst Rev · 2020

PMID: 31981471Meta-AnalysisFull text (PMC)

The effect of cerivastatin therapy on vascular responses to endothelin antagonists in humans.

Leslie Stephen J, Spratt James C, Grieg Lynn et al. · J Cardiovasc Pharmacol · 2004

PMID: 15838335RCT

Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.

Tran D, Lowy A, Howes J B et al. · Diabetes Obes Metab · 2005

PMID: 15811145Trial

Influence of coenzyme Q(10) and cerivastatin on the flow-mediated vasodilation of the brachial artery: results of the ENDOTACT study.

Kuettner Axel, Pieper Anne, Koch Jürgen et al. · Int J Cardiol · 2005

PMID: 15708173Trial

Different effects of pravastatin and cerivastatin on the media of the carotid arteries as assessed by integrated backscatter ultrasound.

Ito Yoko, Kawasaki Masanori, Yokoyama Haruko et al. · Circ J · 2004

PMID: 15277739Trial

Inhibition of HMG-CoA reductase with cerivastatin lowers dense low density lipoproteins in patients with elevated fasting glucose, impaired glucose tolerance and type 2 diabetes mellitus.

Scharnagl H, Winkler K, Mantz S et al. · Exp Clin Endocrinol Diabetes · 2004

PMID: 15146374Trial

Determination of the pharmacokinetics of cerivastatin when administered in combination with sirolimus and cyclosporin A in patients with kidney transplant, and review of the relevant literature.

Renders L, Czock D, Schöcklmann H et al. · Int J Clin Pharmacol Ther · 2003

PMID: 14620947Trial

Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function).

[object Object] · Circulation · 2003

PMID: 12551866Trial

Tacrolimus and cerivastatin pharmacokinetics and adverse effects after single and multiple dosing with cerivastatin in renal transplant recipients.

Renders Lutz, Haas Christian S, Liebelt Jan et al. · Br J Clin Pharmacol · 2003

PMID: 12895195TrialFull text (PMC)

The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction.

Ostadal Petr, Alan David, Hajek Petr et al. · Mol Cell Biochem · 2003

PMID: 12841342Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Cerivastatin (substance)
SNOMED CT: 373443008
UMLS CUI: C0528023
RxNorm CUI: 596723

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.